Type 2: Oramed Sends Oral Insulin Test Request to FDA

trough_level_of_drugs

Israel-based Oramed announced that it has sent an application to the Food and Drug Administration for permission to enter Phase 2 trials of its oral insulin product.

Read more

Posted in Drugs